Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational ...

The Japanese pharma is currently investigating mezagitamab’s potential in two late-stage autoimmune programmes.

Mezagitamab is a fully human IgG1 monoclonal antibody that targets CD38, which is highly expressed on the surface of plasma ...

ETHealthworld.com brings latest blood banks news, views and updates from all top sources for the Indian Health industry.

For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...

Term insurance protects families after death, while health insurance covers medical expenses during life. Many scenarios illustrate the dire consequences of lacking health insurance, highlighting its ...

Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by obstetric morbidity and recurrent ...

Novartis is making further workforce reductions at its U.S. headquarters in New Jersey, planning to remove 114 positions as ...

A patient with three different autoimmune diseases has entered complete remission after undergoing an experimental treatment ...

Emerging data presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting highlighted the ...

Biologic-naïve status and higher inflammation predict rapid skin clearance with psoriasis biologics, while palmoplantar ...